Instalab
logoInstalab

Glucose

Blood Test
Detect type 2 diabetes and prediabetes before symptoms appear.
4.9 (4,993 reviews)
Tested by Quest or Access Medical
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers · 8-hour fast required
Get results
Explained with clear next steps, no medical jargon

Should you take a Glucose test?

This test is most useful if any of these apply to you.

Healthy and Watching Your Diabetes Risk
Screening can find prediabetes or diabetes before symptoms appear, though a fasting result can miss problems after meals.
Concerned About Diabetes in Your Family
A parent or sibling with type 2 diabetes raises your risk and can make earlier screening useful.
Starting Medicines That Can Raise Glucose
Baseline and follow-up results can help detect changes during steroid, statin, or other treatment.
Pregnant or Planning a Pregnancy
Plasma glucose helps assess pregnancy-related risk; a fasting result alone doesn't replace gestational diabetes testing.

About Glucose

Plasma glucose shows how much sugar is circulating when your blood is drawn. It can be measured after fasting, without fasting, or during an oral glucose tolerance test. Those results answer different questions, so the timing matters.

A fasting sample is an established way to detect prediabetes and diabetes before symptoms appear. But insulin resistance can develop while fasting glucose stays steady, and some problems appear only after meals or a glucose drink. One fasting result gives an incomplete picture of your glucose regulation.

What the Number Reflects

Your cells use glucose for energy. After a meal, much of it comes from food. Between meals, your liver releases stored glucose and makes more to maintain the supply. Insulin from your pancreas helps muscle and fat take up glucose and restrains glucose production by the liver.

Type 2 diabetes usually develops when tissues respond less to insulin and the pancreas can no longer produce enough insulin to compensate. Reduced responsiveness is called insulin resistance. Excess glucose production by the liver contributes to rising fasting glucose, but the result also depends on insulin production and other processes. It cannot identify which part of the system is failing.

This test measures glucose in plasma from a blood draw. Plasma is the liquid portion of blood separated from its cells before clotting. The result is reported in mg/dL.

Diabetes and Prediabetes

Fasting plasma glucose, HbA1c, and glucose measured during an oral glucose tolerance test are established tools for diagnosing diabetes. HbA1c estimates average glucose exposure over roughly the previous two to three months. An oral glucose tolerance test measures your response to a standardized glucose drink.

These tests identify overlapping groups of people. In a network meta-analysis using the two-hour glucose tolerance result as the comparison, fasting plasma glucose and HbA1c each missed some cases. Counting either fasting glucose or HbA1c as positive identified more cases than either test alone. That finding doesn't mean a normal fasting result rules out diabetes.

What a Fasting Value Can Miss

Who Was StudiedWhat Was ComparedWhat They Found
Adults in screening studies from seven African countriesHbA1c against an oral glucose tolerance testHbA1c at the usual diagnostic criterion missed a substantial share of the cases identified by the glucose tolerance test.
Adults in pooled studies of prediabetes screeningFasting glucose and HbA1c against glucose tolerance testingFasting glucose missed many people with impaired glucose tolerance. These tests capture different forms of abnormal glucose regulation.
1,797 glucose tolerance test records from a Brazilian laboratoryOne-hour glucose against conventional measuresThe one-hour result identified additional glucose abnormalities. The study was cross-sectional, so it did not establish whether those additional findings predicted future disease.

The one-hour result has enough supporting evidence that the International Diabetes Federation recommends its use in people at risk. The American Diabetes Association's standard diagnostic options still use fasting glucose, HbA1c, the two-hour glucose tolerance result, and a random glucose measurement in someone with classic symptoms. The one-hour measurement can add information, but interpretation should follow a defined testing protocol.

Wearable sensors measure glucose in fluid under the skin. Research has found glucose excursions in people whose standard laboratory results were normal, but the health meaning of every excursion is unsettled. Continuous monitoring has not been established as a substitute for laboratory testing to diagnose prediabetes or diabetes.

Heart, Kidney, and Nerve Risk

Diabetes increases the risk of heart disease and stroke and can damage the eyes, kidneys, and nerves. Long-term glucose exposure contributes to these complications, but a single fasting value cannot measure that exposure or summarize your cardiovascular risk. Blood pressure, cholesterol, smoking, kidney function, and how long you've had diabetes also matter.

Risk develops across a continuum. Observational studies have found that higher fasting plasma glucose predicts future type 2 diabetes even among people who do not meet diagnostic criteria. That association does not establish one lowest-risk target for everyone or prove that lowering an already healthy result with medication improves outcomes.

When Glucose Runs Too Low

Low glucose can impair brain function and cause sweating, shakiness, confusion, seizures, or loss of consciousness. In diabetes, the risk is especially relevant with insulin and medicines that stimulate insulin release. Missed meals, exercise, kidney disease, and other changes can make a previously appropriate treatment plan cause lows.

Severe hypoglycemia is associated with cardiovascular events and death. It can also mark underlying illness or vulnerability, so these associations do not prove that low glucose alone caused every event. A lower result is not automatically a healthier result.

Pregnancy

Maternal glucose crosses the placenta, and high glucose during pregnancy is associated with complications for both mother and baby. In a follow-up study of 4,160 mother-child pairs, children whose mothers had untreated gestational diabetes were more likely to have impaired glucose tolerance at ages 10 to 14. The mothers' classification used fasting and post-drink plasma glucose together, so this finding cannot be attributed to a fasting result alone.

The study supports an association with later childhood glucose regulation. It does not show that one maternal result determines a child's future health or that treatment necessarily prevents every long-term outcome.

Illness, Surgery, and Stress

Illness and surgery can raise glucose through stress hormones, changes in insulin action, and treatment effects. A high result during illness may reflect a temporary response, previously unrecognized diabetes, or both. HbA1c can help assess whether glucose was already running high before the illness, provided nothing is distorting the HbA1c result.

When Results Can Be Misleading

Blood cells keep consuming glucose after collection. Unless the laboratory promptly separates the plasma or uses an effective preservation protocol, the result can be falsely low. Sodium fluoride alone does not stop this process immediately. In a study involving more than 12,000 pregnant women, earlier sample processing increased glucose concentrations and the proportion diagnosed with gestational diabetes.

  • Collection timing: a sample taken after food is a nonfasting result and needs the corresponding interpretation.
  • Recent exercise: activity can temporarily lower glucose, while strenuous exercise can sometimes raise it.
  • Illness or surgery: a stress-related increase is a real biological change, but it may not represent your usual baseline.
  • Medicines: drugs that alter glucose regulation can change the result. Morning fasting measurements may miss the later-day rise caused by some corticosteroid regimens.
  • Different devices: home meters usually display plasma-equivalent values even though they use fingerstick whole blood. Continuous monitors measure fluid under the skin. Neither should be treated as an interchangeable laboratory plasma measurement.

Tracking Your Trend

Fasting glucose varies from day to day. In the Hoorn Study, which included 524 adults tested twice, most of the variation came from normal biological differences between testing days rather than laboratory measurement error.

A persistent upward pattern can add context to your risk, but small changes across a few readings do not necessarily represent disease progression. Comparisons are more useful when the collection conditions are similar. For established diabetes, HbA1c and home or continuous glucose monitoring usually provide more information about treatment response than occasional fasting laboratory measurements alone.

What Moves This Biomarker

Evidence-backed interventions that affect your Glucose level

↓ Decrease
Metformin treatment
Metformin lowers elevated fasting plasma glucose in type 2 diabetes, partly by reducing glucose production by the liver. Randomized placebo-controlled trials directly measured this effect. It has a low risk of hypoglycemia when used alone.
MedicationStrong Evidence
↓ Decrease
Insulin treatment
Insulin lowers plasma glucose when your body cannot supply enough insulin for its needs. It is required in type 1 diabetes and is also used in type 2 diabetes and selected pregnancy-related or illness-related situations. Excess insulin can cause dangerous hypoglycemia, so dosing requires an individualized monitoring plan.
MedicationStrong Evidence
↓ Decrease
GLP-1 receptor agonist treatment
GLP-1 receptor agonists lower fasting plasma glucose and HbA1c in type 2 diabetes and commonly reduce weight. They increase insulin release when glucose is elevated and reduce glucagon release. Hypoglycemia risk is generally low when used alone, but it is not zero and rises when combined with insulin or sulfonylureas.
MedicationStrong Evidence
↓ Decrease
SGLT2 inhibitor treatment
SGLT2 inhibitors lower fasting plasma glucose in type 2 diabetes by increasing glucose loss through urine. They have a low risk of hypoglycemia when used alone. The glucose-lowering effect becomes smaller as kidney function declines.
MedicationStrong Evidence
↑ Increase
Systemic corticosteroid treatment
Corticosteroids such as prednisone can cause substantial hyperglycemia or worsen existing diabetes by impairing insulin action and increasing glucose production. A morning fasting result may remain unchanged even when glucose rises later in the day, so fasting plasma glucose alone can miss the effect.
MedicationStrong Evidence
↑ Increase
PI3K or AKT inhibitor cancer treatment
Some PI3K and AKT inhibitors disrupt signals needed for insulin action and can cause substantial hyperglycemia. In an observational study of 491 people receiving these cancer treatments, management included glucose-lowering medicines and, when necessary, treatment interruptions or dose changes.
MedicationStrong Evidence
↓ Decrease
A structured diet, physical activity, and weight-loss program
Structured lifestyle programs can lower fasting plasma glucose and delay type 2 diabetes in people at high risk. In the Diabetes Prevention Program, the combined intervention reduced diabetes incidence by 58% relative to placebo over an average of 2.8 years.
LifestyleModerate Evidence
↓ Decrease
Regular resistance training
Regular strength training lowers fasting glucose on average in adults with type 2 diabetes. A meta-analysis of randomized trials found improvements in fasting blood glucose and HbA1c, though the studies did not consistently document an identical plasma collection protocol.
ExerciseModerate Evidence
↓ Decrease
Mediterranean or low-glycemic-index eating patterns
These eating patterns can lower fasting glucose in type 2 diabetes. Mediterranean-diet trials include direct measurements of fasting plasma glucose. Reviews of low-glycemic-index diets also report lower fasting glucose, although specimen reporting varies. The size of the change depends on the comparison diet, weight change, medication use, and adherence.
DietModerate Evidence
↓ Decrease
Berberine supplementation
Pooled randomized trials found that berberine lowered fasting plasma glucose in type 2 diabetes. A small placebo-controlled trial in 34 adults with prediabetes also reported improvement. The trials did not detect an increase in hypoglycemia, but the certainty of that safety finding was very low.
SupplementModerate Evidence
↑ Increase
Treatment with glucose-raising antipsychotics or other implicated medicines
Some antipsychotics, thiazide diuretics, and transplant medicines can impair glucose regulation and cause hyperglycemia or diabetes. The effect depends on the specific medicine and dose; it should not be assumed to occur equally with every drug in a class.
MedicationModerate Evidence
↑ Increase
Statin treatment, particularly higher-intensity regimens
Randomized trials show that statins cause a small upward shift in glucose and increase new diabetes diagnoses, particularly in people already close to meeting diagnostic criteria. The adverse glucose effect does not cancel the cardiovascular benefit of an appropriately prescribed statin.
MedicationModest Evidence

Frequently Asked Questions

References

38 studies
  1. American Diabetes Association Professional Practice Committee for DiabetesDiabetes Care2026
  2. National Institute of Diabetes and Digestive and Kidney DiseasesNIDDK
  3. US Preventive Services Task ForceUS Preventive Services Task Force2021
  4. M. Roden, G. ShulmanNature2019

Glucose Testing Options

$19
1 biomarker
$29

See how your body handles sugar in real time, and catch rising diabetes risk years before a fasting test ever notices.

3 biomarkers
$39

Glucose checked every 30 minutes for a detailed curve that catches spikes an hourly test can miss.

5 biomarkers
FSA/HSA eligible
No Rx needed
HIPAA compliant